2型糖尿病合并糖原性肝病1例报告

马仁舒; 武彤; 于鸽; 丛莹; 辛桂杰

doi:10.3969/j.issn.1001-5256.2021.09.035

2型糖尿病合并糖原性肝病1例报告

DOI: 10.3969/j.issn.1001-5256.2021.09.035

吉林大学白求恩第一医院肝胆胰内科，长春 130021

基金项目:

吉林省卫生与健康技术创新项目 (2018J043)

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：马仁舒负责课题设计，资料分析，撰写论文；武彤、于鸽、丛莹参与收集数据，修改论文；辛桂杰负责拟定写作思路，指导撰写文章并最后定稿。

详细信息

通信作者:
辛桂杰，xingj@jlu.ebu.cn

中图分类号: R575
计量
- 文章访问数: 330
- HTML全文浏览量: 262
- PDF下载量: 34
- 被引次数: 0
出版历程
- 收稿日期: 2021-01-25
- 录用日期: 2021-02-10
- 出版日期: 2021-09-20

A case of type 2 diabetes with glycogenic hepatopathy

Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, China

Research funding:

Jilin Province Health Technology Innovation Project (2018J043)

摘要

- 糖原性肝病 /
- 糖尿病, 2型 /
- 诊断
- Glycogenic Hepatopathy /
- Diabetes Mellitus, Type 2 /
- Diagnosis

HTML全文

图 1 肝胆CT平扫结果

注：肝实质密度减低。

下载: 全尺寸图片幻灯片

图 2 肝穿刺活组织检查结果

注：a，肝细胞肿胀，胞浆淡染，细胞膜清晰(HE染色，×400)；b，窦周未见明确纤维化，汇管区未见明确扩张纤维化及界面炎(Masson染色，×400)；c，PAS染色阳性，呈紫红色(×400)；d，D-PAS染色阴性，糖原被消化(×400)。

下载: 全尺寸图片幻灯片

参考文献(11)

[1]	YANG Y, WANG X. Diagnosis and treatment of patients with diabetic hepatopathy[J]. J Prac Hepatol, 2018, 21(4): 653-656. DOI: 10.3969/j.issn.1672-5069.2018.04.050. 杨彦, 王煊. 糖尿病性肝病诊治进展[J]. 实用肝脏病杂志, 2018, 21(4): 653-656. DOI: 10.3969/j.issn.1672-5069.2018.04.050.
[2]	TORBENSON M, CHEN YY, BRUNT E, et al. Glycogenic hepatopathy: An underrecognized hepatic complication of diabetes mellitus[J]. Am J Surg Pathol, 2006, 30(4): 508-513. DOI: 10.1097/00000478-200604000-00012.
[3]	YOUSAF MN, EHSAN H, EHSAN S, et al. Glycogenic hepatopathy: A reversible complication of uncontrolled diabetes mellitus[J]. Cureus, 2020, 12(7): e9323. DOI: 10.7759/cureus.9323.
[4]	SAADI T. Glycogenic hepatopathy: A rare disease that can appear and resolve rapidly in parallel with glycemic control[J]. Isr Med Assoc J, 2012, 14(4): 269-270. http://pdfs.semanticscholar.org/8efb/da77ec7065d1b592ef0cb77cefcac94e153e.pdf
[5]	van den BRAND M, ELVING LD, DRENTH JP, et al. Glycogenic hepatopathy: A rare cause of elevated serum transaminases in diabetes mellitus[J]. Neth J Med, 2009, 67(11): 394-396. http://pdfs.semanticscholar.org/999b/4c99ddf35840ff93cbf2ef1996f51d719771.pdf
[6]	PARMAR N, ATIQ M, AUSTIN L, et al. Glycogenic hepatopathy: Thinking outside the box[J]. Case Rep Gastroenterol, 2015, 9(2): 221-226. DOI: 10.1159/000437048.
[7]	MUKEWAR S, SHARMA A, LACKORE KA, et al. Clinical, biochemical, and histopathology features of patients with glycogenic hepatopathy[J]. Clin Gastroenterol Hepatol, 2017, 15(6): 927-933. DOI: 10.1016/j.cgh.2016.11.038.
[8]	ROSER W, BECKMANN N, WIESMANN U, et al. Absolute quantification of the hepatic glycogen content in a patient with glycogen storage disease by ¹³C magnetic resonance spectroscopy[J]. Magn Reson Imaging, 1996, 14(10): 1217-1220. DOI: 10.1016/s0730-725x(96)00243-3.
[9]	FISCHER MA, NANZ D, REINER CS, et al. Diagnostic performance and accuracy of 3-D spoiled gradient-dual-echo MRI with water- and fat-signal separation in liver-fat quantification: Comparison to liver biopsy[J]. Invest Radiol, 2010, 45(8): 465-470. DOI: 10.1097/RLI.0b013e3181da1343.
[10]	SPRINGER F, MACHANN J, CLAUSSEN CD, et al. Liver fat content determined by magnetic resonance imaging and spectroscopy[J]. World J Gastroenterol, 2010, 16(13): 1560-1566. DOI: 10.3748/wjg.v16.i13.1560.
[11]	MURATA F, HORIE I, ANDO T, et al. A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: The role of image modalities in diagnosing hepatic glycogen deposition including gradient-dual-echo MRI[J]. Endocr J, 2012, 59(8): 669-676. DOI: 10.1507/endocrj.ej12-0081.